Takeda’s Agreement with Adium Pharma

Marval O’Farrell Mairal advised Takeda on the transaction Takeda Pharmaceutical Company Limited  (TSE:4502/NYSE:TAK) has entered into an agreement to divest a selection of non-core products from the...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Lipsa’s $15 Million Notes Offering

Tanoira Cassagne Abogados acted as legal counsel on the transaction Lipsa S.R.L. executed its offering of $15.6 million Classe I “dollar linked” notes. Banco Mariva S.A. acted...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

YPF’s $300 Million Loan

Norton Rose Fulbright and Martínez de Hoz & Rueda advised the Andean Development Corporation, CAF on the transaction YPF and the Andean Development Corporation, CAF signed a...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here